Payment overview · 2025
General Payments
$17.64
1 reported records · 1 companies
Healthcare provider profile · identity verified
Ayodele O Atolagbe, M.D
Allopathic & Osteopathic Physicians|Surgery · JAMAICA, NY · NPI 1255686085
Verified facts
What the public records show
CMS Open Payments records show Ayodele O Atolagbe, M.D received $17.64 in general payments during 2025 across 1 reported records.
Axsome Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $17.64 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $17.64 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $17.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 581 | 120 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 404 | 94 |
| Amlodipine Besylate | Amlodipine Besylate | 391 | 79 |
| Tamsulosin Hcl | Tamsulosin Hcl | 344 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 325 | 59 |
| Metformin Hcl | Metformin Hcl | 301 | 61 |
| Furosemide | Furosemide | 298 | 64 |
| Gabapentin | Gabapentin | 289 | 77 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 258 | 82 |
| Omeprazole | Omeprazole | 224 | 65 |
| Losartan Potassium | Losartan Potassium | 209 | 39 |
| Famotidine | Famotidine | 196 | 31 |
| Levothyroxine Sodium | Levothyroxine Sodium | 163 | 37 |
| Risperidone | Risperidone | 156 | 19 |
| Mirtazapine | Mirtazapine | 150 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 148 | 33 |
| Lisinopril | Lisinopril | 145 | 31 |
| Hydralazine Hcl | Hydralazine Hcl | 137 | 27 |
| Trazodone Hcl | Trazodone Hcl | 135 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 132 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 124 | 30 |
| Eliquis | Apixaban | 121 | 18 |
| Quetiapine Fumarate | Quetiapine Fumarate | 120 | 25 |
| Montelukast Sodium | Montelukast Sodium | 118 | 27 |
| Finasteride | Finasteride | 113 | 17 |
| Simvastatin | Simvastatin | 109 | 14 |
| Nifedipine Er | Nifedipine | 108 | 26 |
| Prednisone | Prednisone | 101 | 49 |
| Fluticasone Propionate | Fluticasone Propionate | 100 | 22 |
| Januvia | Sitagliptin Phosphate | 100 | 17 |
| Aripiprazole | Aripiprazole | 99 | 19 |
| Hydrochlorothiazide | Hydrochlorothiazide | 98 | 27 |
| Carvedilol | Carvedilol | 96 | 17 |
| Linzess | Linaclotide | 95 | 25 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 88 | 27 |
| Jardiance | Empagliflozin | 86 | 19 |
| Benztropine Mesylate | Benztropine Mesylate | 83 | 16 |
| Enalapril Maleate | Enalapril Maleate | 83 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 83 | 22 |
| Roflumilast | Roflumilast | 83 | 13 |
| Olanzapine | Olanzapine | 82 | 13 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 81 | 31 |
| Latanoprost | Latanoprost | 81 | 19 |
| Myrbetriq | Mirabegron | 79 | 13 |
| Alendronate Sodium | Alendronate Sodium | 77 | 19 |
| Ibuprofen | Ibuprofen | 77 | 33 |
| Meclizine Hcl | Meclizine Hcl | 76 | 23 |
| Alcohol Pads | Alcohol Antiseptic Pads | 73 | 25 |
| Labetalol Hcl | Labetalol Hcl | 73 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 73 | suppressed |
| Memantine Hcl | Memantine Hcl | 72 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 71 | 23 |
| Diclofenac Epolamine | Diclofenac Epolamine | 70 | 19 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 70 | 19 |
| Loperamide | Loperamide Hcl | 69 | 20 |
| Meloxicam | Meloxicam | 69 | 30 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 69 | 21 |
| Levetiracetam | Levetiracetam | 67 | 14 |
| Divalproex Sodium | Divalproex Sodium | 66 | 15 |
| Lidocaine | Lidocaine | 66 | 19 |
| Trulicity | Dulaglutide | 63 | 14 |
| Xarelto | Rivaroxaban | 61 | 14 |
| Zafirlukast | Zafirlukast | 60 | 13 |
| Spironolactone | Spironolactone | 59 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 57 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 56 | 28 |
| Mometasone Furoate | Mometasone Furoate | 56 | 17 |
| Divalproex Sodium Er | Divalproex Sodium | 53 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 53 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 51 | suppressed |
| Entresto | Sacubitril/Valsartan | 51 | 11 |
| Azithromycin | Azithromycin | 48 | 32 |
| Glipizide Er | Glipizide | 48 | suppressed |
| Sucralfate | Sucralfate | 48 | suppressed |
| Colchicine | Colchicine | 47 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | suppressed |
| Easy Comfort Pen Needle | Pen Needle, Diabetic | 45 | 13 |
| Nitroglycerin | Nitroglycerin | 44 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 42 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 42 | 19 |
| Ozempic | Semaglutide | 42 | 16 |
| Tradjenta | Linagliptin | 41 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 18 |
| Buspirone Hcl | Buspirone Hcl | 40 | suppressed |
| Naproxen | Naproxen | 40 | 15 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 40 | suppressed |
| Allopurinol | Allopurinol | 39 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 38 | suppressed |
| Methocarbamol | Methocarbamol | 38 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 37 | 16 |
| Farxiga | Dapagliflozin Propanediol | 37 | 13 |
| Clonidine Hcl | Clonidine Hcl | 36 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 36 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 35 | 27 |
| Doxazosin Mesylate | Doxazosin Mesylate | 35 | suppressed |
| Ezetimibe | Ezetimibe | 34 | suppressed |
| Kerendia | Finerenone | 33 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 33 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 32 | suppressed |
| Ketoconazole | Ketoconazole | 31 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | 11 |
| Sertraline Hcl | Sertraline Hcl | 30 | suppressed |
| Digoxin | Digoxin | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | 11 |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Haloperidol | Haloperidol | 27 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 27 | 13 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 27 | 26 |
| Symbicort | Budesonide/Formoterol Fumarate | 27 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 26 | 11 |
| Halobetasol Propionate | Halobetasol Propionate | 25 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 21 |
| Nabumetone | Nabumetone | 25 | suppressed |
| Naproxen-Esomeprazole Mag | Naproxen/Esomeprazole Mag | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | 12 |
| Trulance | Plecanatide | 25 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 22 | suppressed |
| Torsemide | Torsemide | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Bumetanide | Bumetanide | 21 | suppressed |
| Ingrezza | Valbenazine Tosylate | 21 | suppressed |
| Potassium Chloride | Potassium Chloride | 21 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 20 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 19 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Travoprost | Travoprost | 19 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Mirabegron Er | Mirabegron | 18 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Metformin Er Gastric | Metformin Hcl | 17 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Generlac | Lactulose | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 16 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Clonazepam | Clonazepam | 15 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 15 | suppressed |
| Valproic Acid | Valproic Acid | 15 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Fluocinonide | Fluocinonide | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 11 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | 11 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Methazolamide | Methazolamide | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $17.64 · 1 records | Axsome Therapeutics, Inc. | Auvelity | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error